Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Neoplasms 4 Pain, Postoperative 2 Hemangioma, Capillary 2 Carcinoma, Hepatocellular 2 Anxiety Disorders 2 Weight Loss 1 Vomiting 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Shoulder Pain 1 SCLC, Limited Stage 1 Respiratory Aspiration 1 Psychomotor Agitation 1 Prostatic Neoplasms 1 Premature Birth 1 Polycystic Ovary Syndrome 1 Pediatric Obesity 1 Ovarian Cysts 1 Obesity 1 Neuromuscular Diseases 1 Neuroblastoma 1 Nasopharyngeal Carcinoma 1 Myofibroma 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Multiple Myeloma 1 Menstruation Disturbances 1 Lymphoma, Follicular 1 Lung Neoplasms 1

Interventions

Metformin 2 Utrogestan 1 Timolol 1 Tablets 1 Self Care 1 Population Groups 1 Kangaroo-Mother Care Method 1 Inositol 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Premature Birth × Population Groups × Clear all

NCT01434849 2016-11-15

TiPPIH

The University of Texas Health Science Center at San Antonio

Phase 1 Terminated

Hemangioma, Capillary, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon ⚡